by Angela Guess
Christina Farr of VentureBeat reports, "Big data is one of the most over-used buzzwords in the startup vernacular, and founders rarely have the goods to back it up. So you’ll understand that I was intrigued — but highly skeptical — when an email with the subject line 'using data to cure cancer' popped into my inbox. But Ayasdi, a startup that closed $10 million in venture funding today, doesn’t just talk the talk. Stanford researchers have been baking the complex algorithms behind Ayasdi (its quirky name means 'to seek,' in Cherokee) for over a decade, with the goal of unlocking the hidden value in human genetic data."
Farr goes on, "In 2008, the founders, Gurjeet Singh, Dr. Gunnar Carlsson, and Harlan Sexton, decided to commercialize the technology. With the government stepping up its funding for science, they were able to pull in $3.5 million in grants from DARPA, the department of defense agency responsible for building new technology for the military, and the National Science Foundation. The result? A synthesis of machine learning technology and topological data analysis (TDA) that has impressed a score of Silicon Valley investors."
photo credit: Ayasdi